76 related articles for article (PubMed ID: 1769697)
1. Growth inhibition of tumour cells by a liposome-encapsulated, mycolic acid-containing glycolipid, trehalose 2,3,6'-trimycolate.
Ohtsubo Y; Furukawa M; Imagawa T; Sugimoto N; Ikutoh M; Nakatsugi S; Katoh Y; Shinka S; Dohi Y
Immunology; 1991 Nov; 74(3):497-503. PubMed ID: 1769697
[TBL] [Abstract][Full Text] [Related]
2. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
Liepins A; Nowicky JW
Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
[TBL] [Abstract][Full Text] [Related]
3. Induction of tumoricidal activated macrophages by a liposome-encapsulated glycolipid, trehalose 2,3,6'-trimycolate from Gordona aurantiaca.
Furukawa M; Ohtsubo Y; Sugimoto N; Katoh Y; Dohi Y
FEMS Microbiol Immunol; 1990 Sep; 2(2):83-8. PubMed ID: 2257164
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory cytokine production in interferon-gamma-primed mice, challenged with lipopolysaccharide. Inhibition by SK&F 86002 and interleukin-1 beta-converting enzyme inhibitor.
Spinelle-Jaegle S; Devillier P; Doucet S; Millet S; Banissi C; Diu-Hercend A; Ruuth E
Eur Cytokine Netw; 2001; 12(2):280-9. PubMed ID: 11399517
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor is required for the priming of peritoneal macrophages by trehalose dimycolate.
Oswald IP; Dozois CM; Fournout S; Petit JF; Lemaire G
Eur Cytokine Netw; 1999 Dec; 10(4):533-40. PubMed ID: 10586120
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic differences between migration inhibitory factor (MIF) and IFN-gamma for macrophage activation. MIF and IFN-gamma synergize with lipid A to mediate migration inhibition but only IFN-gamma induces production of TNF-alpha and nitric oxide.
Herriott MJ; Jiang H; Stewart CA; Fast DJ; Leu RW
J Immunol; 1993 May; 150(10):4524-31. PubMed ID: 7683323
[TBL] [Abstract][Full Text] [Related]
7. Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and gamma-interferon.
Hori K; Ehrke MJ; Mace K; Mihich E
Cancer Res; 1987 Nov; 47(22):5868-74. PubMed ID: 3117358
[TBL] [Abstract][Full Text] [Related]
8. Regulatory mechanisms for production of IFN-gamma and TNF by antitumor T cells or macrophages in the tumor-bearing state.
Yamamoto N; Zou JP; Li XF; Takenaka H; Noda S; Fujii T; Ono S; Kobayashi Y; Mukaida N; Matsushima K
J Immunol; 1995 Mar; 154(5):2281-90. PubMed ID: 7868900
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha.
Heidenreich S; Weyers M; Gong JH; Sprenger H; Nain M; Gemsa D
J Immunol; 1988 Mar; 140(5):1511-8. PubMed ID: 3126228
[TBL] [Abstract][Full Text] [Related]
10. Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages.
Hori K; Mihich E; Ehrke MJ
Cancer Res; 1989 May; 49(10):2606-14. PubMed ID: 2496917
[TBL] [Abstract][Full Text] [Related]
11. Macrophage activation for microbicidal activity against Leishmania major: inhibition of lymphokine activation by phosphatidylcholine-phosphatidylserine liposomes.
Gilbreath MJ; Nacy CA; Hoover DL; Alving CR; Swartz GM; Meltzer MS
J Immunol; 1985 May; 134(5):3420-5. PubMed ID: 3980997
[TBL] [Abstract][Full Text] [Related]
12. Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins.
Hogan MM; Vogel SN
J Immunol; 1988 Dec; 141(12):4196-202. PubMed ID: 3143760
[TBL] [Abstract][Full Text] [Related]
13. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor.
Howard AD; Erickson KL
Cell Immunol; 1995 Aug; 164(1):105-12. PubMed ID: 7634340
[TBL] [Abstract][Full Text] [Related]
14. [A study on the mechanism of activation of peritoneal exudate macrophages from MRL/MpJ-lpr/lpr mice].
Hashimoto Y
Hokkaido Igaku Zasshi; 1988 Sep; 63(5):781-90. PubMed ID: 2853694
[TBL] [Abstract][Full Text] [Related]
15. Antigen-specific activation of effector macrophages by IFN-gamma producing (TH1) T cell clones. Failure of IL-4-producing (TH2) T cell clones to activate effector function in macrophages.
Stout RD; Bottomly K
J Immunol; 1989 Feb; 142(3):760-5. PubMed ID: 2464024
[TBL] [Abstract][Full Text] [Related]
16. Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes.
Fidler IJ; Fogler WE; Kleinerman ES; Saiki I
J Immunol; 1985 Dec; 135(6):4289-96. PubMed ID: 3934281
[TBL] [Abstract][Full Text] [Related]
17. Reprogramming of lipopolysaccharide-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12.
Shnyra A; Brewington R; Alipio A; Amura C; Morrison DC
J Immunol; 1998 Apr; 160(8):3729-36. PubMed ID: 9558074
[TBL] [Abstract][Full Text] [Related]
18. Priming the macrophage respiratory burst with IL-4: enhancement with TNF-alpha but inhibition by IFN-gamma.
Phillips WA; Croatto M; Hamilton JA
Immunology; 1990 Aug; 70(4):498-503. PubMed ID: 2118480
[TBL] [Abstract][Full Text] [Related]
19. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
Alleva DG; Burger CJ; Elgert KD
J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239
[TBL] [Abstract][Full Text] [Related]
20. Restoration of lipopolysaccharide-mediated cytotoxic macrophage induction in C3H/HeJ mice by interferon-gamma or a calcium ionophore.
Akagawa KS; Kamoshita K; Onodera S; Tokunaga T
Jpn J Cancer Res; 1987 Mar; 78(3):279-87. PubMed ID: 3106284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
